Yonsei Med J.
2011 May;52(3):551-551. 10.3349/ymj.2011.52.3.551.
Retraction: Human Papillomavirus Type 16 E5 Protein as a Therapeutic Target. Yonsei Med J 2006;47(1):1-14
- Affiliations
-
- 1Department of Genetic Engineering, Faculty of Life Science and Technology, Sungkyunkwan University, Suwon, Korea.
- KMID: 1777033
- DOI: http://doi.org/10.3349/ymj.2011.52.3.551
Abstract
- No abstract available.
Reference
-
1. Kim SW, Yang JS. Human papillomavirus type 16 E5 protein as a therapeutic target. Yonsei Med J. 2006. 47(1):1–14.
Article
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Human Papillomavirus Type 16 E5 Protein as a Therapeutic Target
- Immunoinformatics approach for design novel multiepitope prophylactic and therapeutic vaccine based on capsid proteins L1 and L2 and oncoproteins E6 and E7 of human papillomavirus 16 and human papillomavirus 18 against cervical cancer
- Human papillomavirus vaccines: current status and perspectives
- Human Papillomavirus Vaccine
- Synchronous Verrucous Carcinoma and Squamous Cell Carcinoma of Penis by Different Human Papillomavirus Infections
